
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Smad3 CRISPR/Cas9 KO Plasmid (m) | sc-421526 | 20 µg | $397.00 | |||
Smad3 HDR Plasmid (m) | sc-421526-HDR | 20 µg | $445.00 |
Smad3 encodes an intracellular signal transducer that mediates canonical TGF-β/activin signaling by forming complexes with SMAD4 and regulating transcriptional programs downstream of receptor kinase activation. In mouse cells, SMAD3 controls context-dependent gene expression linked to cell-cycle regulation, extracellular matrix production, epithelial–mesenchymal transition, and immune modulation, integrating cross-talk with MAPK, PI3K/AKT, and inflammatory NF-κB pathways. Altered Smad3 activity is associated with dysregulated fibrotic responses, aberrant tissue remodeling, and changes in immune homeostasis, making it a key node for studying cytokine-driven transcriptional networks. Smad3-dependent signaling is also widely used as a mechanistic readout for pathway perturbations in development and stress-response models.
Smad3 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Smad3 gene in mouse cell lines. Each plasmid in the pool co-expresses a unique sgRNA, targeting a distinct site within the Smad3 locus, alongside the Streptococcus pyogenes Cas9 nuclease, and encodes GFP to enable fluorescent identification and enrichment of successfully transfected cells. This multi-guide strategy increases the likelihood of inducing frameshifts or deletions that produce a functional knockout, offering a more robust alternative to single-guide approaches. DSBs induced at multiple sites are resolved through non-homologous end joining (NHEJ) or, when used with the included HDR donor template, homology-directed repair (HDR) at a defined target site within the locus.
When used in conjunction with the RFP-expressing HDR donor, GFP and RFP fluorescence can be used together to distinguish transfected from edited cell populations, streamlining flow cytometry-based sorting and clone selection workflows.
For applications requiring confirmed, selectable knockout clones, Smad3 HDR Plasmid (m) includes an HDR donor construct containing a puromycin resistance cassette (PuroR) and a red fluorescent protein (RFP) reporter, flanked by homology arms specific to a defined Smad3 target site.
When co-transfected with Smad3 CRISPR/Cas9 KO Plasmid (m):
The HDR donor construct features loxP sites flanking the PuroR-RFP selection cassette to allow clean marker removal following clone confirmation. Transient expression of Cre recombinase via the included Cre Vector: sc-418923 excises the cassette, leaving a minimal residual loxP site within the Smad3 locus and eliminating potential confounding effects on downstream assays.
This two-step approach:
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.